Gabriel Brooks's Insider Trades & SAST Disclosures
Gabriel Brooks's most recent trade in Solid Biosciences Inc was a trade of 10,937 Restricted Stock Units done . Disclosure was reported to the exchange on Feb. 13, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Gabriel Brooks.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Solid Biosciences Inc
|
Gabriel Brooks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 10,937 | 32,813 | - | - | Restricted Stock Units | |
|
Solid Biosciences Inc
|
Gabriel Brooks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 10,937 | 26,068 (0%) | 0% | - | Common Stock | |
|
Solid Biosciences Inc
|
Gabriel Brooks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 3.96 per share. | 13 Feb 2025 | 3,256 | 22,812 (0%) | 0% | 4.0 | 12,894 | Common Stock |
|
Solid Biosciences Inc
|
Gabriel Brooks | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 112,900 | 112,900 | - | - | Restricted Stock Units | |
|
Solid Biosciences Inc
|
Gabriel Brooks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Oct 2024 | 9,750 | 29,250 | - | - | Restricted Stock Units | |
|
Solid Biosciences Inc
|
Gabriel Brooks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Oct 2024 | 9,750 | 13,902 (0%) | 0% | - | Common Stock | |
|
Solid Biosciences Inc
|
Gabriel Brooks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.50 per share. | 18 Oct 2024 | 2,923 | 10,979 (0%) | 0% | 6.5 | 19,000 | Common Stock |
|
Solid Biosciences Inc
|
Gabriel Brooks | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 87,500 | 87,500 | - | - | Employee Stock Option (Right to Buy) | |
|
Solid Biosciences Inc
|
Gabriel Brooks | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 43,750 | 43,750 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges